FDA Grants Orphan Drug Designation to Novel Mesothelioma Treatment – Asbestos.com 4 hours ago Mesothelioma Share/Print
J & J Faces New Mesothelioma and Ovarian Cancer Suit from Black Women’s Group – Mesothelioma.net Blog 4 hours ago Mesothelioma Share/Print
The Mesothelioma Options Help Center of Florida Endorses The Steinberg Law Group as the Top Mesothelioma Law – EIN News 1 day ago Mesothelioma Share/Print
Researcher Hopes to Improve Tumor Treating Fields for Mesothelioma – Asbestos.com 1 day ago Mesothelioma Share/Print
What Are the Most Common Signs of Pleural Mesothelioma? – Mesothelioma Guide 1 day ago Mesothelioma Share/Print
The Mesothelioma Options Help Center of Texas Endorses The Steinberg Law Group as the Top Mesothelioma Law – EIN News 2 days ago Mesothelioma Share/Print
Novel Mesothelioma Treatment Oncofid-P Granted FDA Orphan Drug Status – Targeted Oncology 2 days ago Mesothelioma Share/Print
Mesothelioma Compensation Center Has Endorsed Attorney Erik Karst of Karst von Oiste To Make Certain a Person with Mesothelioma Receives the Best Compensation-Harder Working Lawyers-Better Results – PRNewswire 2 days ago Mesothelioma Share/Print
Fidia announces the FDA Orphan Drug designation for ONCOFID®-P for the treatment of malignant mesothelioma, the cancer caused by exposure to asbestos – PRNewswire 2 days ago Mesothelioma Share/Print
ChronLAW.com News for attorneys, lawyers, and insurance, banking, credit, finance, government, education and law related professionals, covering politics, business, medicine, crime, law enforcement and other legal topics.